Qualitek Labs Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange under SEBI regulations for the quarter and financial year ended March 31, 2026. The submission, dated April 06, 2026, fulfills the company's regulatory obligations under the Securities and Exchange Board of India framework.

Regulatory Compliance Certificate

The company submitted its certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was provided by Skyline Financial Services Private Limited, which serves as the company's Registrar and Share Transfer Agent.

Dematerialization Status

The certificate confirms that no physical share certificates were received for dematerialization from depository participants during the quarter ended March 31, 2026. This indicates that the company's shares remain fully dematerialized with no pending conversion requests.

Shareholding Distribution

As of March 31, 2026, the company's shareholding pattern shows complete dematerialization across two major depositories:

Transaction Summary

The Registrar and Share Transfer Agent reported no share transfer transactions during the period. The summary shows:

• No transfer requests received or processed
• No transmission, transposition, or other corporate actions
• No requests rejected or pending
• All records updated in the register of members as of March 31, 2026

Corporate Information

Qualitek Labs Limited, incorporated with CIN L74999DL2018PLC334105, maintains its registered office at 73, National Park, Lajpat Nagar IV, New Delhi, and corporate office at C-40, Sector 57, Noida. The compliance certificate was signed by Managing Director Antaryami Nayak (DIN: 07232463) and authorized by Parveen Sharma from Skyline Financial Services Private Limited.

Qualitek Labs Limited has announced a Live Investor Relations (IR) Interaction scheduled for February 21, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the Bombay Stock Exchange on February 17, 2026, about this upcoming virtual engagement with investors.

Event Details

The investor relations interaction will be conducted in a virtual format, providing accessibility to a broader investor base. The event is structured as a general interaction session rather than a formal analyst or earnings call.

Key Participants

The interaction will feature two primary participants who will engage with the investor community. Mr. Antaryami Nayak, Managing Director of Qualitek Labs Limited, will represent the company's leadership perspective. Dr. Nikesh Yadav from Investor and Microcap Research will also participate in the session.

Interaction Scope and Compliance

The company has clearly outlined that the interaction is intended to facilitate general discussions with investors regarding the business overview and growth outlook. Qualitek Labs Limited has emphasized that this session does not constitute an analyst or earnings call, maintaining transparency about the nature of the engagement.

In adherence to regulatory requirements, the company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the course of the interaction. This commitment ensures compliance with SEBI guidelines and maintains fair disclosure practices.

Regulatory Compliance

The announcement fulfills the disclosure requirements under Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015. As an entity listed on the BSE SME Platform with scrip code 544091, Qualitek Labs Limited has provided the necessary intimation to the exchange within the prescribed regulatory framework.

Additional information about the interaction is available on the company's website at www.qualiteklab.com/compliances/ , providing investors with easy access to relevant details and ensuring transparent communication.